August 24, 2021 Comments Off on New patent for Boehringer Ingelheim drug TRIJARDY XR Posted in: Patent Added Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are fourteen…
The post New patent for Boehringer Ingelheim drug TRIJARDY XR appea…
August 24, 2021 Comments Off on New patent for Boehringer Ingelheim drug JARDIANCE Posted in: Patent Added Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appear…
